Enveric Biosciences, Inc. (ENVB): Depreciation & Amortization
$200.9K
Year ended 2025-12-31
$153.9K
Trailing 12 months to 2026-06-30
-15.1%
3-year compound annual growth
+10.7%
5-year compound annual growth
+1.9%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $200.9K | -40.5% | 2026-03-27, From 2025-01-01 |
| 2024-12-31 | $337.5K | -1.9% | 2026-03-27, From 2024-01-01 |
| 2023-12-31 | $344.0K | +4.9% | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | $327.9K | -50.1% | 2024-03-26, From 2022-01-01 |
| 2021-12-31 | $656.6K | +443.3% | 2023-06-09, From 2021-01-01 |
| 2020-12-31 | $120.9K | -94.7% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $2.27M | -22.0% | 2020-08-12, From 2019-01-01 |
| 2018-12-31 | $2.90M | -9.7% | 2020-08-12, From 2018-01-01 |
| 2017-12-31 | $3.22M | +136.4% | 2019-03-26, From 2017-01-01 |
| 2016-12-31 | $1.36M | +719.0% | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | $166.2K | n/a | 2017-04-04, From 2015-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | 2025-12-31 | $200.9K | -40.5% |
| Petros Pharmaceuticals, Inc. (PTPI) | 2024-12-31 | $2.83M | -13.8% |
| Azitra, Inc. (AZTR) | 2025-12-31 | $138.1K | +5.2% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $615.7K | -11.6% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $43.3K | +269.5% |
| International Stem Cell Corp (ISCO) | 2025-12-31 | $219.0K | +6.3% |
| AEON Biopharma, Inc. (AEON) | 2025-12-31 | $78.0K | -19.6% |
| Ernexa Therapeutics Inc. (ERNA) | 2025-12-31 | $65.0K | -53.2% |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $87.8K | +15.3% |
Compare ENVB, PTPI, AZTR, QUCY side by side · Screen every company in Pharmaceutical Preparations ↗